课题基金 / 基金详情

VIRAL PROTEINS THAT INHIBIT FAS AND TNFR1 SIGNALING

VIRAL PROTEINS THAT INHIBIT FAS AND TNFR1 SIGNALING
抑制 FAS 和 TNFR1 信号传导的病毒蛋白
批准号:
6497719
负责人:
Linda R Gooding
金额:
$29.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 2004-01-31

项目摘要

项目成果

Linda R Gooding的其他基金

相关文献

中文摘要
翻译
描述(改编自《调查员摘要》):调查员 已经确定并开始对一系列独特的蛋白质进行表征, 编码在人腺病毒的E3转录单位内。其中两个 这些被称为10.4K和14.5K的蛋白质形成了一层膜 抑制连接TNFR1或Fas引发的细胞凋亡的异源二聚体, 但不包括其他的细胞凋亡激活剂。10.4K/14.5K复合体在 至少有两种不同的封锁功能:它会导致地表消失 一些病毒感染细胞上的相关Fas,从而阻止信号转导 通过Fas;它还抑制受体后的Fas和TNFR1信号 绑定步骤。最近,他们发现10.4K和14.5K 从病毒感染细胞的裂解物中独立地与Fas共沉淀。 本申请中描述的实验将确定分子 这些蛋白质干扰细胞凋亡的机制。特指 他们将:1)确定在已知的TNFR1和Fas成员中, 信号复合体,结合到10.4K和14.5K,以及在 作为这种绑定的结果,出现了信号复杂;2)确定 杂二聚体导致表面Fas丢失的机制和 10.4K、14.5K与Fas相关性的亚细胞定位; 以及3)确定10.4K/14.5K动作对 导致细胞破坏的细胞凋亡机制。
英文摘要
DESCRIPTION (Adapted from the Investigator's abstract): The investigator has identified and begun to characterize a series of unique proteins, encoded within the E3 transcription unit of human adenoviruses. Two of these proteins, called 10.4K and 14.5K, form a membrane associated heterodimer that inhibits apoptosis triggered by ligation of TNFR1 or Fas, but not other apoptotic activators. The 10.4K/14.5K complex mediates at least two different blockade functions: it causes disappearance of surface associated Fas on some virus infected cells, thereby blocking signaling through Fas; and it also inhibits Fas and TNFR1 signaling at a post-receptor binding step. Most recently they have found that both 10.4K and 14.5K independently co-precipitate with Fas from lysates of virus-infected cells. Experiments described in this application will determine the molecular mechanisms by which these proteins interfere with apoptosis. Specifically they will: 1) determine which, among the known members of the TNFR1 and Fas signaling complexes, bind to 10.4K and 14.5K, and what disruption in the signaling complex occurs as a consequence of this binding; 2) determine the mechanism by which the heterodimer causes loss of surface Fas and the subcellular localization of the association between 10.4K, 14.5K, and Fas; and 3) determine the functional outcome of 10.4K/14.5K action on the apoptotic machinery leading to cellular destruction.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
The adenovirus e3 promoter is sensitive to activation signals in human T cells.
腺病毒 e3 启动子对人类 T 细胞中的激活信号敏感。
DOI: 10.1128/jvi.77.2.1112-1119.2003
发表时间: 2003
期刊: Journal of virology
影响因子: 5.4
作者: [Mahr,JeffreyA, Boss,JeremyM, Gooding,LindaR]
通讯作者: Gooding,LindaR
The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.
人腺病毒早期区域 3 蛋白(gp19K、10.4K、14.5K 和 14.7K)在小鼠肺炎模型中的作用。
DOI: 10.1128/jvi.70.4.2431-2439.1996
发表时间: 1996
期刊: Journal of virology.
影响因子: --
作者: [Sparer,TE, Tripp,RA, Dillehay,DL, Hermiston,TW, Wold,WS, Gooding,LR]
通讯作者: Gooding,LR
Adenoviral inhibitors of apoptotic cell death.
细胞凋亡的腺病毒抑制剂。
DOI: 10.1016/s0168-1702(02)00122-3
发表时间: 2002
期刊: Virus research
影响因子: 5
作者: [McNees,AdrienneL, Gooding,LindaR]
通讯作者: Gooding,LindaR
Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis.
E1A 对肿瘤坏死因子的易感性诱导取决于与 p300 或 p105-Rb 的结合以及 DNA 合成的诱导。
DOI: 10.1128/jvi.70.1.68-77.1996
发表时间: 1996
期刊: Journal of virology
影响因子: 5.4
作者: [Shisler,J, Duerksen-Hughes,P, Hermiston,TM, Wold,WS, Gooding,LR]
通讯作者: Gooding,LR
共 8 条
    Adenovirus Persistence in Human Lymphoid Tissues
    • 批准号:
      6706225
    • 项目类别:
    • 资助金额:
      $34.2万
    • 财政年份:
      2003
    • 负责人:
      Linda R Gooding
    • 依托单位:
    Adenovirus Persistence in Human Lymphoid Tissues
    • 批准号:
      6611613
    • 项目类别:
    • 资助金额:
      $34.2万
    • 财政年份:
      2003
    • 负责人:
      Linda R Gooding
    • 依托单位:
    Adenovirus Persistence in Human Lymphoid Tissues
    • 批准号:
      7024533
    • 项目类别:
    • 资助金额:
      $33.4万
    • 财政年份:
      2003
    • 负责人:
      Linda R Gooding
    • 依托单位:
    Adenovirus Persistence in Human Lymphoid Tissues
    • 批准号:
      7188050
    • 项目类别:
    • 资助金额:
      $32.43万
    • 财政年份:
      2003
    • 负责人:
      Linda R Gooding
    • 依托单位: